Table 1 Data set sizes (number of patients)
From: Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
Treatment | Variant | Number of patients (pre-treatment) | Number of patients (≥1 day post-treatment) | Number of patients (≥5 day post-treatment) | Number of patients (≥10 day post-treatment) | Number of patients (≥14 day post-treatment) |
|---|---|---|---|---|---|---|
Casirivimab and imdevimab | BA.1 | 137 | 85 | 73 | 64 | 58 |
Casirivimab and imdevimab | BA.2 | 0 | 11 | 12 | 12 | 12 |
Casirivimab and imdevimab | Delta | 1557 | 227 | 123 | 67 | 50 |
Molnupiravir | BA.1 | 1411 | 150 | 104 | 67 | 41 |
Molnupiravir | BA.2 | 228 | 17 | 11 | 8 | 5 |
Molnupiravir | Delta | 24 | 7 | 6 | 4 | 1 |
Paxlovid | BA.1 | 276 | 18 | 8 | 6 | 2 |
Paxlovid | BA.2 | 598 | 40 | 15 | 10 | 5 |
Paxlovid | Delta | 0 | 1 | 1 | 1 | 1 |
Remdesivir | BA.1 | 872 | 397 | 305 | 258 | 227 |
Remdesivir | BA.2 | 187 | 92 | 76 | 65 | 65 |
Remdesivir | Delta | 3054 | 703 | 334 | 201 | 133 |
Sotrovimab | BA.1 | 3221 | 380 | 240 | 148 | 114 |
Sotrovimab | BA.2 | 1338 | 112 | 50 | 25 | 18 |
Sotrovimab | Delta | 24 | 5 | 5 | 2 | 2 |
